Peptides derived from HIV-1 vif: a non-substrate based novel type of HIV-1 protease inhibitors 1 1 Edited by J. Karn (original) (raw)
Peptides derived from HIV-1 vif: a non-substrate based novel type of HIV-1 protease inhibitors
Chaim Gilon
Journal of Molecular Biology, 1999
View PDFchevron_right
Human immunodeficiency virus type 1 Vif-derived peptides inhibit the viral protease and arrest virus production
Nissim Chen
Febs Letters, 1998
View PDFchevron_right
Peptide inhibitors of HIV-1 protease and viral infection of peripheral blood lymphocytes based on HIV-1 Vif
David Volsky
Proceedings of the National Academy of Sciences, 1998
View PDFchevron_right
Design, Synthesis and Screening of Novel PCU-peptide/peptoid Derived HIV Protease Inhibitors
Maya Makatini
View PDFchevron_right
Abrogation of Vif function by peptide derived from the N-terminal region of the human immunodeficiency virus type 1 (HIV-1) protease
marina hutoran
Virology, 2004
View PDFchevron_right
Design and synthesis of inhibitors for the HIV-1 protease
Nicholas Camp
1994
View PDFchevron_right
Potency Comparison of Peptidomimetic Inhibitors against HIV-1 and HIV-2 Proteinases: Design of Equipotent Lead Compounds
Juraj Sedláček
Archives of Biochemistry and Biophysics, 1997
View PDFchevron_right
An Orally Bioavailable HIV1 Protease Inhibitor Containing an Imidazole-Derived Peptide Bond Replacement: Crystallographic and Pharmacokinetic Analysis
Sherin S. Abdel-Meguid
Biochemistry, 1994
View PDFchevron_right
Cyclic HIV protease inhibitors capable of displacing the active site structural water molecule
Bruce Aungst
Drug Discovery Today, 1997
View PDFchevron_right
Inhibitors of HIV Protease: Unique Non‐peptide Active Site Templates
Christopher Gajda
Journal of Molecular Recognition, 1996
View PDFchevron_right
Small-Molecule Inhibitors of HIV-1 Protease Dimerization Derived from Cross-Linked Interfacial Peptides
Michael Shultz
Angewandte Chemie International Edition, 2000
View PDFchevron_right
Molecular Recognition of Macrocyclic Peptidomimetic Inhibitors by HIV1 Protease † , ‡
David Fairlie
Biochemistry, 1999
View PDFchevron_right
Substrate-Based Cyclic Peptidomimetics of Phe-Ile-Val That Inhibit HIV-1 Protease Using a Novel Enzyme-Binding Mode
Jakob Begun
Journal of the American Chemical Society, 1996
View PDFchevron_right
Future appeal of comparative studies on putative binding sites of HIV-1 virus-encoded proteolytic enzyme inhibitor of different Food and Drug Administration-approved compounds
SAMI MELEBARI
HIV & AIDS Review
View PDFchevron_right
Two-step binding mechanism for HIV protease inhibitors
Thomas Spector
Biochemistry, 1992
View PDFchevron_right
Pentacycloundecane derived hydroxy acid peptides: A new class of irreversible non-scissile ether bridged type isoster as potential HIV-1 wild type C-SA protease …
Yasien Sayed
Bioorganic …, 2011
View PDFchevron_right
Inhibition of HIV by an anti-HIV protease synthetic peptide blocks an early step of viral replication
Jean-alain Fehrentz
Research in Virology, 1992
View PDFchevron_right
Discovery and optimization of nonpeptide HIV-1 protease inhibitors
John Domagala
Bioorganic & Medicinal Chemistry, 1996
View PDFchevron_right
Pentacycloundecane derived hydroxy acid peptides: A new class of irreversible non-scissile ether bridged type isoster as potential HIV-1 wild type C-SA protease inhibitors
Gert Kruger
Bioorganic Chemistry, 2012
View PDFchevron_right
Development and Identification of a Novel Anti-HIV-1 Peptide Derived by Modification of the N-Terminal Domain of HIV-1 Integrase
Michele Manfra
Frontiers in Microbiology, 2016
View PDFchevron_right
Structural Basis of HIV-1 and HIV-2 Protease Inhibition by a Monoclonal Antibody
J. Lescar
Structure, 2001
View PDFchevron_right
Development of peptide inhibitors of HIV transmission
vivek kumar
Bioactive Materials, 2016
View PDFchevron_right
Structure–activity relationship of HIV-1 protease inhibitors containing α-hydroxy-β-amino acids. Detailed study of P1 site
Shuichi Miyamoto
Bioorganic & Medicinal Chemistry, 1999
View PDFchevron_right
A Novel Nonpeptide HIV-1 Protease Inhibitor: Elucidation of the Binding Mode and Its Application in the Design of Related Analogs
Donna Ferguson
Journal of Medicinal Chemistry, 1994
View PDFchevron_right
Conformationally constrained HIV-1 protease inhibitors
Joseph Vacca
Bioorganic & Medicinal Chemistry Letters, 1994
View PDFchevron_right
A New Generation of Peptide-based Inhibitors Targeting HIV-1 Reverse Transcriptase Conformational Flexibility
Pascal Clayette
Journal of Biological Chemistry, 2009
View PDFchevron_right
Inhibition of HIV1 replication by a peptide dimerization inhibitor of HIV1 protease
Cara Brown
Antiviral Research, 2006
View PDFchevron_right
Human immunodeficiency virus type 1 Vif binds the viral protease by interaction with its N-terminal region
marina hutoran
The Journal of general virology, 2002
View PDFchevron_right
Antiviral agent based on the non-structural protein targeting the maturation process of HIV-1: expression and susceptibility of chimeric Vpr as a substrate for cleavage by HIV-1 protease
Irene Weber
Protein Engineering Design and Selection, 2000
View PDFchevron_right
Structure of a non-peptide inhibitor complexed with HIV-1 protease. Developing a cycle of structure-based drug design
D. Decamp, Elaine Meng
The Journal of biological chemistry, 1993
View PDFchevron_right
Pentacycloundecane-diol-Based HIV-1 Protease Inhibitors: Biological Screening, 2 D NMR, and Molecular Simulation Studies
Bahareh Honarparvar, Yasien Sayed
ChemMedChem, 2012
View PDFchevron_right